| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/29/2008 | US7364804 Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative |
| 04/29/2008 | CA2425494C Process for making 3-amino-2-chloro-4-methylpyridine |
| 04/29/2008 | CA2268957C Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/24/2008 | WO2008048866A2 Bicyclic heteroaromatic compounds |
| 04/24/2008 | WO2008048683A2 Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via 1h-imidazo[4,5-c]quinolin-4-phthalimide intermediates |
| 04/24/2008 | WO2008048538A1 Hiv integrase inhibitors |
| 04/24/2008 | WO2008047952A2 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound |
| 04/24/2008 | WO2008047951A2 An alzheimer' s disease progression inhibitor containing heterocyclic compound |
| 04/24/2008 | WO2008047831A1 Jak inhibitor |
| 04/24/2008 | WO2008047307A1 Pyrido [2, 3-d] pyrimidines and their use as kinase inhibitors |
| 04/24/2008 | WO2008047201A2 Solid dispersion comprising a poorly water soluble drug |
| 04/24/2008 | WO2008046982A2 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 |
| 04/24/2008 | WO2008046919A2 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 04/24/2008 | WO2008046802A1 Phenylacetamides useful as protein kinase inhibitors |
| 04/24/2008 | WO2008046532A1 Method for producing pradofloxacin |
| 04/24/2008 | WO2008046497A1 3 -amino-imidazo [1,2 -a] pyridine derivatives having an sglt1 and sglt2 inhibiting action, for treating type 1 and type 2 diabetes |
| 04/24/2008 | WO2008046135A1 Novel anxiolytic compounds |
| 04/24/2008 | WO2008019967A3 Phenyl, pyridine and quinoline derivatives |
| 04/24/2008 | WO2008009415A3 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080097094 cis-6-(3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane; for controlling synaptic transmission, neurotransmitter release; Alzheimer's disease, Parkinson's disease, attention deficit disorder, depression, nicotinic withdrawal syndrome, Tourette's syndrome, schizophrenia and pain |
| 04/24/2008 | US20080096913 peroxisome proliferator-activated receptor agonists; congestive heart failure, atherosclerosis, arteriosclerosis, obesity, hyperlipidemia, hypoalphalipoproteinemia, Syndrome X, diabetes, insulin resistance; 3-[5-Methoxy-1-(3-methoxy-benzyl)-1H-indol-3-yl]-propionic acid |
| 04/24/2008 | US20080096912 Indole, azaindole and related heterocyclic pyrrolidine derivatives |
| 04/24/2008 | US20080096903 inhibitors of disease-related target, Heat Shock Protein 90 (HSP90); antiproliferative; 2-chloro-5'-sulfamoyladenosine analogs; derivatives of adenine and other purines; Sulfamic Acid 2-[6-amino-2-fluoro-8-(6-iodo-benzo[1,3]dioxol-5-ylmethyl)-purin-9-yl]-ethyl ester |
| 04/24/2008 | US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 04/24/2008 | US20080096867 Imidazo[1,2-A] Pyridine Anxiolytics |
| 04/24/2008 | DE102006057580B3 New 3,4-diaminopyridine derivatives useful as catalysts in a chemical reaction including acylation reaction of alcohols, or in urethane and/or a polyurethane synthesis |
| 04/24/2008 | DE102006049520A1 Verfahren zur Herstellung von Pradofloxacin Process for preparing pradofloxacin |
| 04/24/2008 | CA2672926A1 Bicyclic heteroaromatic compounds |
| 04/24/2008 | CA2666932A1 Process for preparing pradofloxacin |
| 04/24/2008 | CA2666590A1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 04/24/2008 | CA2666375A1 3-aminoimidazo[1,2-a]pyridine derivatives having an sglt1- and sglt2- inhibiting action for the treatment of type 1 and type 2 diabetes |
| 04/24/2008 | CA2666360A1 An alzheimer's disease progression inhibitor containing heterocyclic compound having specific structure |
| 04/24/2008 | CA2666219A1 Novel anxiolytic compounds |
| 04/24/2008 | CA2666116A1 Phenylacetamides useful as protein kinase inhibitors |
| 04/24/2008 | CA2665538A1 Hiv integrase inhibitors |
| 04/24/2008 | CA2665384A1 Pyrido [2, 3-d] pyrimidines and their use as kinase inhibitors |
| 04/24/2008 | CA2660166A1 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 |
| 04/23/2008 | EP1914236A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/23/2008 | EP1914235A1 Chiral tetra-hydro beta-carboline derivatives and applications thereof as antiparasitic compounds |
| 04/23/2008 | EP1914234A1 Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors |
| 04/23/2008 | EP1912998A1 Pyrazole derivatives having tyrosinkinase activity |
| 04/23/2008 | EP1912989A2 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 04/23/2008 | EP1912988A1 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 04/23/2008 | EP1912987A1 Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents |
| 04/23/2008 | EP1912986A1 Imidiazo -and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 04/23/2008 | EP1912985A1 Imidazopyridine derivatives as cannabinoid receptor ligands |
| 04/23/2008 | EP1912966A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| 04/23/2008 | EP1912644A2 N-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives, preparation and use thereof |
| 04/23/2008 | EP1802622B1 Halogenation of rylen-carboximides with elementary halogen in a two-phase mixture comprising an organic solvent and water, wherein formed halogen hydrocide is continuously removable from the organic solvent |
| 04/23/2008 | EP1718648B1 Tricyclic imidazopyridines and intermediates for the synthesis thereof |
| 04/23/2008 | EP1716150B1 Substituted heterocyclic compounds and methods of use |
| 04/23/2008 | EP1631571B1 Novel intermediate for the preparation of therapeutically active imidazopyridines |
| 04/23/2008 | EP1534716B1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1313735B1 Liquid crystalline 3,4:9,10-perylenetetracarboxylic acid diimides |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP0984928B1 Heterocyclic nitrato derivatives |
| 04/23/2008 | CN101166741A Process for making fluorinated 4-azasteroid derivatives and intermediates thereof |
| 04/23/2008 | CN101166740A Imidazo (1,2-a) pyridine derivatives useful as peptide deformylase (PDF) inhibitors |
| 04/23/2008 | CN101166739A Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof |
| 04/22/2008 | US7361767 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 04/22/2008 | US7361766 N-(1-Benzyl-2-oxo-1,2,3,4-tetrahydro-1,6-naphthyridin-3-yl)-benzenesulfonamide; CB-1 antagonist; regulating appetitive behavior |
| 04/22/2008 | US7361765 resides in the superior properties of the succinate salt of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine |
| 04/22/2008 | US7361764 Pyrrolo-pyridine kinase modulators |
| 04/22/2008 | US7361763 to treat diseases mediated by kinase activity; for example: 2-diethylamino-5-[3-(2-methoxy-phenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethyl-nicotinamide |
| 04/22/2008 | US7361762 Process for preparing acid salts of Gemifloxacin |
| 04/22/2008 | US7361761 Process for the preparation of bisphosphonic acid |
| 04/22/2008 | US7361760 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361680 Indole compounds useful for the treatment of cancer |
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361663 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 04/22/2008 | US7361662 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 04/22/2008 | US7361657 Drugs for treatment of respiratory syncytial virus and salt formation |
| 04/22/2008 | CA2270777C Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 04/17/2008 | WO2008046084A2 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008046049A1 Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
| 04/17/2008 | WO2008045688A1 Chymase inhibitors |
| 04/17/2008 | WO2008045543A1 Substituted 4h-imidazo [4, 5, 1-ij] [1, 6] naphthyridine-9-amines and their pharmaceutical use |
| 04/17/2008 | WO2008045529A1 Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases |
| 04/17/2008 | WO2008045484A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044045A1 Pharmaceutical combinations |
| 04/17/2008 | WO2008043791A2 Thiophene derivatives for treating hepatitis c |
| 04/17/2008 | WO2008043733A1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents |
| 04/17/2008 | WO2005047266A9 Aryl imidazoles and their use as anti-cancer agents |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090853 Methyl 2-[4-({[2-[2-(2,3-difluorophenyl)ethyl]-4-oxo-1(4H)-quinazolinyl]acetyl}-{[4'-(trifluoromethyl)-4-biphenylyl]methyl}amino)-1-piperidinyl]-2-methylpropanoate, or a salt thereof; preventing or treating diseases such as atherosclerosis, diabetes, rheumatoid arthritis, stroke, inflammation |
| 04/17/2008 | US20080090847 Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090845 Haloalkyl-substituted pyrimidinone derivatives |
| 04/17/2008 | US20080090818 (4-Morpholin-4-yl-phenyl)-[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]-amine; mitogen-activated protein kinase and matrix metallo proteinase inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis |
| 04/17/2008 | US20080090817 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase |
| 04/17/2008 | US20080090816 Anti-infective biaryl compounds |
| 04/17/2008 | US20080090807 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |